NIH opens study to treat parasitic infections like malaria and worms

NCT ID NCT00001645

Recruiting now Disease control Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 29, 2026 · Updated 4 times

Summary

This study at the National Institutes of Health evaluates and treats people aged 3 and older with known or suspected parasitic infections, such as malaria, intestinal worms, and others. Participants receive standard medical care, not experimental treatments. The goal is to monitor and treat the infection using approved methods. Up to 800 people will be enrolled.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could improve standard care and monitoring for people with parasitic infections.
What could go wrong: This is an observational and treatment study, not a trial of a new drug. It uses existing treatments, so no breakthrough is expected. Results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ECHINIOCOCCUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

echinococcosis giardiasis intestinal helminthiasis malaria parasitic infectious disease protozoa infectious disease strongyloidiasis Trematode Infections

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ECHINIOCOCCUS GI PROTOZOA INTESTINAL WORMS MALARIA STRONGYLOIDES

Contacts and locations

Locations

National Institutes of Health Clinical Center
RECRUITING

Bethesda, Maryland, 20892, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.